GOLO diet gains attention for hormone-focused plan and proprietary Release supplement
GOLO diet uses hormone-balance principles and a proprietary ‘Release’ supplement; company-funded studies report weight loss, but independent evidence remains limited.
The GOLO diet, which centers on balancing hormones and pairing individualized meal plans with a proprietary supplement called Release, has drawn attention for its reported weight-loss results. GOLO promotes portion-controlled, whole-food meals alongside the Release capsule, arguing that hormone regulation can address cravings, fatigue and overeating. Company-published trials claim substantial average weight loss, but independent reviewers note limitations in study design and disclosure.
GOLO diet framework centers on hormone balance
The program positions hormone balance as the primary driver of appetite, metabolism and weight management rather than strict macronutrient prohibition. GOLO materials list symptoms they associate with hormone imbalance, including binge or emotional eating, fatigue, persistent hunger and poor sleep. The company argues that addressing hormonal regulation, alongside diet and exercise, improves long-term weight control.
Release capsule is central to the company’s protocol
GOLO markets the Release capsule as a patented, plant-extract and mineral supplement intended to complement meals and blunt cravings while supporting blood-sugar regulation. Program instructions call for taking the capsule with meals and recommend adjusting dosage if a person loses weight rapidly or reaches specified targets. The capsule is described as a proprietary blend, and GOLO does not publish exact ingredient quantities, a point that has raised questions among clinicians about transparency.
Meal plans emphasize portion control and balanced choices
GOLO’s meal guidance is personalized, with users assigned servings of protein, carbohydrates, fats and vegetables based on energy needs and activity levels. Typical recommendations include whole grains and fruits for carbohydrates, avocados and nuts for healthy fats, and a range of proteins from plant and animal sources, with vegetables emphasized at every meal. Example menus promoted by GOLO include poached eggs with whole-grain toast and mashed avocado for breakfast, a grilled-chicken salad for lunch, hummus and vegetables for a snack, and a six-ounce salmon portion with asparagus for dinner.
Company-funded trials report large average weight loss
GOLO has published study results claiming meaningful reductions in weight and waist circumference for program participants, including an average loss reported as 37.4 pounds, or roughly 16.1 percent of body weight, and an average waist reduction of 6.4 inches. The company also cites a randomized, double-blind, placebo-controlled trial in which participants taking the Release capsule lost significantly more weight and waist inches than those on placebo. However, those studies involved a small sample—68 participants in the cited research—and were funded and conducted by GOLO, limiting the generalizability of the findings.
Safety questions and special-population guidance remain
GOLO states the Release capsule is generally well tolerated and lists no commonly reported side effects, but the proprietary nature of the blend means specific ingredient amounts are not disclosed. That lack of transparency complicates assessment of allergy risk, drug interactions and suitability for people with medical conditions. GOLO advises people with type 1 diabetes to consult a physician before use and recommends that pregnant or breastfeeding individuals avoid the supplement; clinicians say anyone with chronic health issues or on medication should seek professional guidance before beginning the program.
Cost and adherence factors affect real-world outcomes
The company markets the Release capsule alongside membership and coaching options, and a single bottle of the supplement is promoted at a price point of $59.95, with additional costs for multi-month supplies or program services. Observers note that the structured meal plans, portion rules and accompanying exercise guidance used in GOLO studies likely contributed to weight loss independently of the supplement, meaning adherence and lifestyle changes remain critical variables. For many consumers, recurring program expenses and the need for sustained behavior change are practical considerations when evaluating the plan.
Consumer advocates and many nutrition experts urge caution when interpreting company-reported results and recommend looking for independent, peer-reviewed research that discloses methodology and ingredient levels. Prospective users should weigh the claimed benefits against limited external evidence, consider potential interactions with medications, and consult a registered dietitian or physician to ensure the plan is appropriate for their medical history and goals.
While GOLO promotes a combined approach of meal personalization and a proprietary supplement to address hormone-related drivers of weight, evidence beyond company-funded studies is sparse and ingredient transparency is limited. Individuals interested in the GOLO diet should evaluate costs, testability and safety, and seek professional advice to make an informed decision about whether the program fits their needs.
